| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Klichinsky Michael | Chief Scientific Officer | 3675 MARKET STREET, SUITE 401, PHILADELPHIA | /s/ Michael Klichinsky | 08 Oct 2025 | 0001967221 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CARM | Common Stock | Options Exercise | $6,268 | +56,982 | $0.1100 | 56,982 | 07 Oct 2025 | Direct | ||
| transaction | CARM | Common Stock | Sale | $14,485 | -56,982 | -100% | $0.2542 | 0 | 07 Oct 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CARM | Stock Option (right to buy) | Options Exercise | $0 | -56,982 | -100% | $0.000000 | 0 | 07 Oct 2025 | Common Stock | 56,982 | $0.1100 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2441 to $0.2647, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F2 | The option was fully vested. |